PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Stem Cell Clinical Research Institute, the First Affiliated Hospital of Dalian Medical University, Dalian 116000, Liaoning, China.\', \'Dalian Stem Cell and Precision Medicine Innovation Institute, Dalian 116000, Liaoning, China.\', \'College of Life Sciences, Liaoning Normal University, Dalian 116029, Liaoning, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.13345/j.cjb.200216
?:hasPublicationType
?:journal
  • Sheng wu gong cheng xue bao = Chinese journal of biotechnology
is ?:pmid of
?:pmid
?:pmid
  • 33169563
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.132
?:rankingScore_hIndex
  • 16
is ?:relation_isRelatedTo_publication of
?:title
  • [Mesenchymal stem cells in the treatment of COVID-19-progress and challenges].
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33169563>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33169563>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all